Villa-Moruzzi E, Puntoni F, Marin O
Department of Biomedicine, University of Pisa, Italy.
Int J Biochem Cell Biol. 1996 Jan;28(1):13-22. doi: 10.1016/1357-2725(95)00119-0.
Three Protein Phosphatase-1 (PP1) isoforms (PP1 alpha, PP1 gamma-1 and PP1 delta) are found in skeletal muscle. These are bound to regulatory subunits, such as inhibitor 2 (I2) in the cytosol and G in the glycogen and microsomal fractions. In vitro, the PP1-12 complex is activated by Glycogen Synthase Kinase-3 (GSK-3 or FA). We investigated the activities and protein levels of the three PP1 isoforms and of GSK-3 in muscle of mdx dystrophic mice. PP1 was assayed as phosphorylase phosphatase, in the presence of 5 nM okadaic acid (which inhibits PP2A). Peptide antibodies were produced and used to investigate PP1 alpha, PP1 gamma-1 and PP1 delta. GSK-3 was assayed using a previously described peptide. This was synthesized in a pre-phosphorylated from, which avoids the additional use of Casein Kinase II. Higher PP1 activity was assayed in the cytosol from mdx rather than from control muscles. Immunoprecipitation indicated that only PP1 alpha and PP1 gamma-1 were more active. This was most likely due to enzyme activation, since the immunodetected proteins were unchanged. On the other hand, the immunodetected PP1 delta was lower in the glycogen and microsomal fractions from mdx muscle. GSK-3 was more active in the mdx extract Selective immunoprecipitation of GSK-3 alpha and GSK-3 beta indicated that both isoforms were activated. In the case of GSK-3 beta, the immunodetected protein was also increased. The changes described herein may be related to the pathological events occurring in the mdx muscle. These include increased protein degradation and turnover, and fibre regeneration. In fact, the decreased PP1 delta may be due to protein degradation and the increased GSK-3 may be the consequence of increased protein turnover or regeneration. The apparent correlation between the increased PP1 alpha and PP1 gamma-1 activities and the increased GSK-3 may agree with the hypothesis that GSK-3 activates the newly synthesized PP1.
在骨骼肌中发现了三种蛋白磷酸酶-1(PP1)亚型(PP1α、PP1γ-1和PP1δ)。它们与调节亚基结合,如胞质溶胶中的抑制剂2(I2)以及糖原和微粒体部分中的G。在体外,PP1-I2复合物被糖原合酶激酶-3(GSK-3或FA)激活。我们研究了mdx营养不良小鼠肌肉中三种PP1亚型和GSK-3的活性及蛋白水平。在存在5 nM冈田酸(抑制PP2A)的情况下,将PP1作为磷酸化酶磷酸酶进行测定。制备了肽抗体并用于研究PP1α、PP1γ-1和PP1δ。使用先前描述的肽对GSK-3进行测定。该肽以预磷酸化形式合成,避免了额外使用酪蛋白激酶II。在mdx小鼠的胞质溶胶中检测到的PP1活性高于对照肌肉。免疫沉淀表明只有PP1α和PP1γ-1更具活性。这很可能是由于酶的激活,因为免疫检测到的蛋白没有变化。另一方面,在mdx肌肉的糖原和微粒体部分中,免疫检测到的PP1δ较低。GSK-3在mdx提取物中更具活性。对GSK-3α和GSK-3β的选择性免疫沉淀表明两种亚型均被激活。就GSK-3β而言,免疫检测到的蛋白也增加了。本文所述的变化可能与mdx肌肉中发生的病理事件有关。这些包括蛋白质降解和周转率增加以及纤维再生。事实上,PP1δ的减少可能是由于蛋白质降解,而GSK-3的增加可能是蛋白质周转率增加或再生的结果。PP1α和PP1γ-1活性增加与GSK-3增加之间的明显相关性可能与GSK-3激活新合成的PP1这一假设相符。